These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3300713)

  • 1. Brucellosis and immunity: humoral and cellular components in mice.
    Plommet M
    Ann Inst Pasteur Microbiol; 1987; 138(1):105-10. PubMed ID: 3300713
    [No Abstract]   [Full Text] [Related]  

  • 2. Human immune response to Brucella infection.
    Serre A; Bascoul S; Vendrell JP; Cannat A
    Ann Inst Pasteur Microbiol; 1987; 138(1):113-7. PubMed ID: 3300715
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccines, vaccination in brucellosis.
    Plommet M; Serre A; Fensterbank R
    Ann Inst Pasteur Microbiol; 1987; 138(1):117-21. PubMed ID: 3300716
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of levamisole in murine brucellosis.
    Young EJ; McMillan K
    J Infect Dis; 1987 Sep; 156(3):530-1. PubMed ID: 3611839
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.
    Bascoul S; Cannat A; Huguet MF; Serre A
    Immunology; 1978 Aug; 35(2):213-21. PubMed ID: 750371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practical value of examining cellular immunity in human brucellosis].
    Bertrand A; Siffert M; Bascoul S; Mathieu-Daudé JC
    Dev Biol Stand; 1984; 56():537-46. PubMed ID: 6489630
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-brucella antibodies in blood donors (author's transl)].
    Fernandez MN; Daza RM; Orden B; Royo G; SanJuan I; Cabrera R; Zabala P; Barbolla L
    Sangre (Barc); 1981; 26(3):360-6. PubMed ID: 7292222
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum-mediated immune cellular responses to Brucella melitensis. VI. The sequence of cellular and serologic changes after immunization of the rabbit with the Rev I vaccine strain.
    Ralston DJ; Elberg SS
    J Infect Dis; 1971 Jun; 123(6):595-602. PubMed ID: 4106742
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulating activity of Brucella fractions in a human lymphocyte transformation test. Correlation with humoral and cellular immunity.
    Bascoul S; Peraldi M; Merino AL; Lacave C; Cannat A; Serre A
    Immunology; 1976 Nov; 31(5):717-22. PubMed ID: 992708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunoblotting study of serologic response in patients with acute brucellosis.
    Leiva León J; de la Rosa M; Plata J; Martínez MJ; Jiménez-Alonso J
    Diagn Microbiol Infect Dis; 1991; 14(6):515-8. PubMed ID: 1802541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dynamics of lymphocyte subpopulations, immunoglobulins and specific antibodies in acute brucellosis].
    Mukovozova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):85-9. PubMed ID: 3799106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective antigens in brucellosis.
    Dubray G
    Ann Inst Pasteur Microbiol; 1987; 138(1):84-7. PubMed ID: 3300720
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular responses to "brucelline INRA" during the experimental brucellosis of the mouse.
    Bureau JP; Caravano R; Garelli L; Lemaire J
    Immunobiology; 1989 Mar; 179(1):8-16. PubMed ID: 2659500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
    Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between the duration of the clinical course of human brucellosis and the avidity of specific IgG antibodies].
    Gutiérrez J; Rodríguez M; Maroto MC
    Rev Med Chil; 1995 Jul; 123(7):819-22. PubMed ID: 8560111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
    Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
    Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific IgE response in patients with brucellosis.
    Araj GF; Lulu AR; Khateeb MI; Haj M
    Epidemiol Infect; 1990 Dec; 105(3):571-7. PubMed ID: 2249721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamics of the humoral immunity indices in patients with subacute brucellosis being treated with levamisole].
    Mukovozova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):56-9. PubMed ID: 3499730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.
    Araya LN; Elzer PH; Rowe GE; Enright FM; Winter AJ
    J Immunol; 1989 Nov; 143(10):3330-7. PubMed ID: 2509555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.